Our Vision for the Future
Innovative Solutions
We’re committed to creating innovative cancer diagnostics that enhance patient care
Global Impact
Our technology has the potential to make a global difference in cancer diagnosis
Empowering Healthcare
We aim to empower healthcare professionals with reliable and efficient tools for diagnosis
The Purpose of Our Product
To make the diagnosis of prostate cancer faster, more cost-effective, objective and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples.
2018
Founded
10 MSEK
In capital
10 000
New prostate cancer cases every year in Sweden
1,4 million
Cases worldwide
Our Product – Cellda® Prostate
Cellda®Prostate is providing faster, more accurate, and objective diagnosis. It is based years of research, expertise, and a deep commitment to improving healthcare for patients worldwide.
Our product, Cellda®Prostate, is intended for the automatic analysis of digital images of prostate biopsies, distinguishing between normal and abnormal samples. It seamlessly integrates into the standard workflow of pathology labs.
With Cellda®Prostate, we aim to empower healthcare professionals with a powerful tool that enhances the quality of patient care and contributes to the ongoing fight against prostate cancer. Explore how Cellda® Prostate is shaping the future of cancer diagnosis and treatment.
Message from the CEO
“We're at the forefront of cancer diagnostics”
…pioneering innovative solutions for prostate cancer diagnosis. Our commitment to excellence drives us to create cutting-edge technology that revolutionizes healthcare. Join us on this journey towards a healthier future.
– Susanne Bredenberg, CEO Cellda AB
